作者:
Marcio Gerhardt,Soeiro-de-Souza [1]
;
Antonio L,Teixeira [2]
;
Elvis C,Mateo [2]
;
Marcus V,Zanetti [3]
;
Flavia G,Rodrigues [2]
;
Vanessa J,de Paula [4]
;
Julia F,Bezerra [4]
;
Ricardo A,Moreno [1]
;
Wagner F,Gattaz [3]
;
Rodrigo,Machado-Vieira [5]
作者单位:
Mood Disorders Program (GRUDA), Institute and Department of Psychiatry, University of Sao Paulo, Brazil.
[1]
Laboratory of Immunopharmacology, IBC, Federal University of Minas Gerais, Brazil.
[2]
Laboratory of Neuroscience, LIM-27, Institute and Department of Psychiatry, University of Sao Paulo, Brazil; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo, Brazil.
[3]
Laboratory of Neuroscience, LIM-27, Institute and Department of Psychiatry, University of Sao Paulo, Brazil.
[4]
Laboratory of Neuroscience, LIM-27, Institute and Department of Psychiatry, University of Sao Paulo, Brazil; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo, Brazil; ETPB, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, and Department of Health and Human Services, Bethesda, MD, United States. Electronic address: machadovieirar@gmail.com.
[5]
DOI
10.1016/j.euroneuro.2014.03.005
PMID
24731723
发布时间
2014-06-17